Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | +2.60% | -4.24% | +3.27% |
Apr. 22 | Transcript : Lexicon Pharmaceuticals, Inc. - Analyst/Investor Day | |
Mar. 25 | Lexicon Pharmaceuticals Files Prospectus for Secondary Offering | MT |
Business Summary
Number of employees: 285
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +766.19% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +766.19% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lonnel Coats
CEO | Chief Executive Officer | 58 | 14-07-06 |
Jeffrey Wade
DFI | Director of Finance/CFO | 59 | 98-12-31 |
Craig Granowitz
CTO | Chief Tech/Sci/R&D Officer | 60 | 21-08-01 |
Investor Relations Contact | 45 | Nov. 12 | |
Tom Garner
PRN | Corporate Officer/Principal | - | 23-10-08 |
Wendy Mcdermott
HRO | Human Resources Officer | - | 21-12-31 |
Comptroller/Controller/Auditor | 56 | 17-05-31 | |
General Counsel | - | 14-11-03 | |
Brian Crum
LAW | General Counsel | 51 | 00-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Lefkowitz
BRD | Director/Board Member | 80 | 01-01-31 |
Ray Debbane
CHM | Chairman | 69 | 07-07-31 |
Director/Board Member | 65 | 07-08-27 | |
Philippe Amouyal
BRD | Director/Board Member | 65 | 07-07-31 |
Judith Swain
BRD | Director/Board Member | 75 | 07-08-31 |
Lonnel Coats
CEO | Chief Executive Officer | 58 | 14-07-06 |
Samuel Barker
BRD | Director/Board Member | 81 | 00-02-29 |
Diane Sullivan
BRD | Director/Board Member | 62 | 23-07-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 247,104,726 | 242,135,683 ( 97.99 %) | 867,973 ( 0.3513 %) | 97.99 % |
Company contact information
Lexicon Pharmaceuticals, Inc.
2445 Technology Forest Boulevard 11th floor
77381-1160, The Woodlands
+
http://www.lexpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.27% | 379M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- LXRX Stock
- Company Lexicon Pharmaceuticals, Inc.